购物车
- 全部删除
- 您的购物车当前为空
DOTA Zoledronate represents a novel, advanced compound utilized specifically in bone-targeted radionuclide therapy to diagnose bone metastases.
DOTA Zoledronate represents a novel, advanced compound utilized specifically in bone-targeted radionuclide therapy to diagnose bone metastases.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 期货 |
产品描述 | DOTA Zoledronate represents a novel, advanced compound utilized specifically in bone-targeted radionuclide therapy to diagnose bone metastases. |
体外活性 | DOTA-Zoledronate is a promising agent for the development of other future-oriented radionuclide therapy concepts for personalized nuclear oncology[1]. |
分子量 | 701.564 |
分子式 | C23H41N7O14P2 |
CAS No. | 1908409-18-6 |
密度 | 1.68 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容